Vertex Pharmaceuticals

Joshua Boger, Ph.D., founded Vertex in 1989 with $6 million in venture capital and a dream to create a new kind of pharmaceutical company. After more than a decade at Merck, where he was told that most of the medicines he would work on would never make it to a patient, he left and founded Vertex with the idea that no challenge should ever be too great. From the very first day, Vertex has pushed the boundaries of what’s possible in medicine with the simple goal of improving the lives of people with serious diseases. Vertex Pharmaceuticals Incorporated is a global biotechnology company committed to the discovery and development of breakthrough small molecule drugs for serious diseases. The Company's strategy is to commercialize its products both independently and in collaboration with major pharmaceutical companies.
Type
Public
HQ
Boston, US
Founded
1989
Employees
1,950 (est)+11%

Key People at Vertex Pharmaceuticals

Kenneth L. Horton

Kenneth L. Horton

Executive Vice President and Chief Legal Officer
Ian F. Smith

Ian F. Smith

Executive Vice President & CFO
Thomas F. Connolly

Thomas F. Connolly

Senior Vice President, Human Resources
Stuart A. Arbuckle

Stuart A. Arbuckle

Executive Vice President and Chief Commercial Officer
Amit K. Sachdev

Amit K. Sachdev

Senior Vice President,Global Government Strategy, Market Access and Value
Larry Bock

Larry Bock

Co-Founder

Vertex Pharmaceuticals Locations

Boston, US

Vertex Pharmaceuticals Metrics

Vertex Pharmaceuticals Summary

Founding Date

1989

Market capitalization

$18.7 B

Closing share price

$77.8

Vertex Pharmaceuticals Market Value History

Vertex Pharmaceuticals News

Vertex Pharmaceuticals Company Life

You may also be interested in